Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Changes in Stockholders??? Deficit

v3.25.1
Consolidated Statements of Changes in Stockholders’ Deficit - USD ($)
Total
Conversion of convertible secured debentures to Common Stock
Exchange of Convertible Secured Debentures to Series A Preferred Stock
Conversion of Series A Preferred Stock to Common Stock
Series A Preferred Stock
Series A Preferred Stock
Exchange of Convertible Secured Debentures to Series A Preferred Stock
Series A Preferred Stock
Conversion of Series A Preferred Stock to Common Stock
Common Stock
Common Stock
Conversion of convertible secured debentures to Common Stock
Common Stock
Conversion of Series A Preferred Stock to Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Conversion of convertible secured debentures to Common Stock
Additional Paid-in Capital
Exchange of Convertible Secured Debentures to Series A Preferred Stock
Additional Paid-in Capital
Conversion of Series A Preferred Stock to Common Stock
Accumulated other Comprehensive Loss
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2022         0     1,312,521                
Beginning Balance at Dec. 31, 2022 $ 27,819       $ 0     $ 131     $ 68,132,790       $ 0 $ (68,105,102)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Foreign currency translation adjustment 0                              
Stock-based compensation 4,427,073                   4,427,073          
Settlement of liquidated damages (in shares)               52,502                
Settlement of liquidated damages 3,685,629             $ 6     3,685,623          
Exercise of stock options (in shares)               6,329                
Exercise of stock options 421,175             $ 1     421,174          
Vesting of RSUs (in shares)               13,929                
Vesting of RSUs 0             $ 1     (1)          
Exercise of warrants (in shares)               4,603                
Exercise of warrants 338,055                   338,055          
Conversion of convertible secured debentures to Common Stock 0                              
Net loss (50,686,601)                             (50,686,601)
Ending Balance (in shares) at Dec. 31, 2023         0     1,389,884                
Ending Balance at Dec. 31, 2023 (41,786,850)       $ 0     $ 139     77,004,714       0 (118,791,703)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Foreign currency translation adjustment (42,229)                           (42,229)  
Stock-based compensation $ 2,303,054                   2,303,054          
Exercise of stock options (in shares) 0                              
Reverse stock split round up (in shares)               133,975                
Reverse stock split round up $ 0             $ 13     (13)          
Vesting of RSUs (in shares)               108,662                
Vesting of RSUs 0             $ 11     (11)          
Restricted stock forfeited for taxes (in shares)               (3,688)                
Exercise of warrants (in shares)               653,818                
Exercise of warrants 4,635,257             $ 65     4,635,192          
Conversion of convertible secured debentures (in shares)           35,434 (400)   5,517,889 554,931            
Conversion of convertible secured debentures to Common Stock 110,300,191 $ 29,741,859 $ 110,300,191 $ 0   $ 4 $ 0   $ 552 $ 55   $ 29,741,307 $ 110,300,187 $ (55)    
At the Market (ATM) share offering (in shares)               1,406,424                
At the Market (ATM) share offering 9,357,954             $ 141     9,357,813          
Net loss (134,906,649)                             (134,906,649)
Ending Balance (in shares) at Dec. 31, 2024         35,034     9,761,895                
Ending Balance at Dec. 31, 2024 $ (20,397,413)       $ 4     $ 976     $ 233,342,188       $ (42,229) $ (253,698,352)